Back to News
Market Impact: 0.35
What Insulet (PODD) Said on Its Q3 Earnings Call
Source: marketbeat.com
Corporate EarningsCompany FundamentalsHealthcare & BiotechCorporate Guidance & Outlook
Insulet reported third-quarter revenue of $842 million, up 19.2% year over year on a reported basis and 19.6% at constant currency. International growth outpaced the company's plans, while U.S. performance was within its guidance range.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
PODD0.45
More News
- TD Cowen raises Insulet stock price target to $163 on Omnipod strength
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- A blue wave sends futures into the green
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh
- Snap shares fall over 10% on third-quarter earnings miss
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Which AI Investment Research Platforms Are SOC 2 Certified?
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper